GEODE CAPITAL MANAGEMENT, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1214717 BOSTON, MA

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,741,586,360

+$29,629,910 QoQ

Shares Held

6,139,621

+2.6% QoQ

Ownership

2.42%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.8636886543974.ToString("F0")% Shared 0.ToString("F0")% None 0.13631134560260316.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,556,641,344 across 524 Biotechnology names. VRTX ranks #1 (14.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

All Filings in VRTX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,741,586,360	6,139,621	+2.6%	Shares	Defined	2026-05-15
2025-12-31	$2,711,956,450	5,981,905	+0.1%	Shares	Defined	2026-02-09
2025-09-30	$2,339,557,491	5,973,745	+0.8%	Shares	Defined	2025-11-12
2025-06-30	$2,639,478,164	5,928,747	+2.9%	Shares	Defined	2025-08-08
2025-03-31	$2,793,416,482	5,761,760	+2.0%	Shares	Defined	2025-05-13
2024-12-31	$2,274,544,636	5,648,236	-4.8%	Shares	Defined	2025-02-12
2024-09-30	$2,760,662,790	5,935,888	-6.2%	Shares	Defined	2024-11-12
2024-06-30	$2,964,798,365	6,325,308	+8.8%	Shares	Defined	2024-08-09
2024-03-31	$2,429,907,178	5,813,036	+2.5%	Shares	Defined	2024-05-13
2023-12-31	$2,308,457,456	5,673,419	+1.4%	Shares	Defined	2024-02-13
2023-09-30	$1,945,943,998	5,595,974	+0.9%	Shares	Defined	2023-11-13
2023-06-30	$1,951,292,034	5,544,861	+2.5%	Shares	Defined	2023-08-11
2023-03-31	$1,704,294,602	5,409,257	+0.5%	Shares	Defined	2023-05-15
2022-12-31	$1,554,421,592	5,382,719	+2.1%	Shares	Defined	2023-02-13
2022-09-30	$1,526,358,463	5,271,667	+16.3%	Shares	Defined	2022-11-14
2022-06-30	$1,277,772,246	4,534,484	+4.7%	Shares	Defined	2022-08-12
2022-03-31	$1,130,060,384	4,330,231	-0.6%	Shares	Defined	2022-05-13
2021-12-31	$956,625,912	4,356,220	+1.3%	Shares	Defined	2022-02-11
2021-09-30	$780,403,629	4,302,352	+5.3%	Shares	Defined	2021-11-12
2021-06-30	$824,097,901	4,087,179	+3.7%	Shares	Defined	2021-08-13
2021-03-31	$846,921,459	3,941,186	+1.4%	Shares	Defined	2021-05-12
2020-12-31	$918,616,473	3,886,843	+0.3%	Shares	Defined	2021-02-12
2020-09-30	$1,054,234,241	3,874,152	+0.9%	Shares	Defined	2020-11-13
2020-06-30	$1,114,882,427	3,840,317	+0.8%	Shares	Defined	2020-08-13
2020-03-31	$906,439,828	3,809,371	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.